A Primer on Cardiovascular Gene Therapy for the Practitioner: What Clinicians Need to Know

Cindy S. Argueta Portillo; Andrew P. Landstrom

doi:10.1016/j.cjca.2025.11.034

journal article May 01, 2026

A Primer on Cardiovascular Gene Therapy for the Practitioner: What Clinicians Need to Know

Cindy S. Argueta Portillo Andrew P. Landstrom

Canadian Journal of Cardiology Vol. 42 No. 5 pp. 1040-1043 · Elsevier BV

View at Publisher Save 10.1016/j.cjca.2025.11.034

Topics

No keywords indexed for this article. Browse by subject →

References

5

[1]

Dewars "The genetic basis of sudden cardiac death: from diagnosis to emerging genetic therapies" Annu Rev Med (2025) 10.1146/annurev-med-042423-042903

[2]

Kim "Gene therapy in cardiovascular disease: recent advances and future directions in science: a science advisory from the American Heart Association" Circulation (2024)

[3]

Dotzler "Suppression-replacement KCNQ1 gene therapy for type 1 long QT syndrome" Circulation (2021) 10.1161/circulationaha.120.051836

[4]

Lyon "Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL" Gene Ther (2020) 10.1038/s41434-020-0171-7

[5]

Vrellaku "A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders" Mol Ther (2024) 10.1016/j.ymthe.2024.07.016

Metrics

1

Citations

5

References

Details

Published: May 01, 2026
Vol/Issue: 42(5)
Pages: 1040-1043
License: View

Authors

C

Cindy S. Argueta Portillo

A

Andrew P. Landstrom

Cite This Article

Cindy S. Argueta Portillo, Andrew P. Landstrom (2026). A Primer on Cardiovascular Gene Therapy for the Practitioner: What Clinicians Need to Know. Canadian Journal of Cardiology, 42(5), 1040-1043. https://doi.org/10.1016/j.cjca.2025.11.034

A Primer on Cardiovascular Gene Therapy for the Practitioner: What Clinicians Need to Know

You May Also Like